The Globe and Mail reports in its Thursday, March 6, edition that National Bank Financial analyst Zachary Evershed has reiterated his "outperform" ranking for DRI Healthcare Trust. The Globe's David Leeder writes in the Eye On Equities column that Mr. Evershed gave his unit target a 50-cent boost to $18. Analysts on average target the units at $19.19. Mr. Evershed says in a note: "As the existing portfolio alone boasts a FCF yield in the low 20s, we see a compelling entry point with a free option on the growth potential from new deployments. With growing confidence in the trust's growth prospects and governance, we reiterate our 'outperform' rating." The Globe reported on July 10 that Mr. Evershed said "caution" was warranted at DRI Heathcare, which was then trading at $12.27. The Globe reported on Jan. 4 that CIBC Asset Management manager Craig Jerusalim had named DRI Healthcare a top pick for 2025. The units were then going for $11.72. The Globe reported on Feb. 21 that Mr. Evershed had reaffirmed his "outperform" recommendation for DRI Healthcare. The units could then be had for $11.38.